World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
52371
World Ranking
13384
National Ranking
187

Loreto Carmona publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Loreto Carmona sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 519 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Loreto Carmona D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Loreto Carmona sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Loreto Carmona is a researcher affiliated with the Instituto de Salud Musculoesquelética in Spain. Their body of work is primarily situated within the field of Medicine, with a significant focus on Rheumatology, as well as related subfields including Hematology, Infectious Diseases, Immunology, and Surgery.

Their research topics cover a broad array of areas such as Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders, COVID-19 Clinical Research, Spondyloarthritis Studies, Fibromyalgia and Chronic Fatigue Syndrome, Systemic Lupus Erythematosus, and SARS-CoV-2 and COVID-19 Research.

Loreto Carmona has contributed extensively to the scientific literature, with notable recent papers including:

  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry, 2020, Annals of the Rheumatic Diseases
  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry, 2021, Annals of the Rheumatic Diseases
  • 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis, 2021, Annals of the Rheumatic Diseases
  • EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2, 2020, Annals of the Rheumatic Diseases
  • Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study, 2020, Annals of the Rheumatic Diseases

The research output of Loreto Carmona has frequently been published in a number of medical journals, particularly:

  • Annals of the Rheumatic Diseases
  • RMD Open
  • Rheumatology International
  • Reumatología Clínica (English Edition)
  • Reumatología Clínica

Collaboration represents a key aspect of Loreto Carmona's research. Frequent co-authors include Laure Gossec, Elsa F Mateus, Anja Strangfeld, Pedro Machado, and Kimme L Hyrich, with each having co-authorship counts ranging from 30 to 36 joint works.

Best Publications

  • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

    Christopher J.L. Murray;Theo Vos;Rafael Lozano;Mohsen Naghavi

  • Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

    Theo Vos;Abraham D. Flaxman;Mohsen Naghavi;Rafael Lozano

  • Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report

    Juan J. Gómez-Reino;Loreto Carmona;Vicente Rodríguez Valverde;Emilio Martín Mola

  • The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

    Marita Cross;Emma Smith;Damian G Hoy;Loreto Carmona

  • Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Milena Gianfrancesco;Kimme L Hyrich;Sarah Al-Adely;Loreto Carmona

  • The burden of musculoskeletal diseases in the general population of Spain: results from a national survey

    L Carmona;J Ballina;R Gabriel;A Laffon

  • Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

    Loreto Carmona;Juan J. Gómez-Reino;Vicente Rodríguez-Valverde;Dolores Montero

  • Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative

    K Visser;W Katchamart;E Loza;J A Martinez-Lopez

  • EULAR recommendations for the management of familial Mediterranean fever

    Seza Ozen;Erkan Demirkaya;Burak Erer;Avi Livneh

  • Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.

    Anja Strangfeld;Martin Schäfer;Milena A Gianfrancesco;Saskia Lawson-Tovey

  • The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

    I. Solovic;M. Sester;J. J. Gomez-Reino;H. L. Rieder

  • Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography

    E Naredo;G Bonilla;F Gamero;J Uson

  • 2018 update of the EULAR recommendations for the management of hand osteoarthritis

    Margreet Kloppenburg;Féline P.B. Kroon;Francisco J. Blanco;Michael Doherty

  • Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.

    Juan J Gómez-Reino;Loreto Carmona;Miguel Angel Descalzo

  • European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

    Marta Mosca;C. Tani;M. Aringer;S. Bombardieri

  • Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: Predictive value in disease activity and radiologic progression

    Esperanza Naredo;Paz Collado;Ana Cruz;Mercedes J. Palop

  • The prevalence of rheumatoid arthritis in the general population of Spain.

    L Carmona;V Villaverde;C Hernández-García;J Ballina

  • Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain.

    A J Mas;L Carmona;M Valverde;B Ribas

  • Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period

    Juan J Gomez-Reino;Loreto Carmona

  • Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis.

    Esperanza Naredo;Ingrid Möller;Ana Cruz;Loreto Carmona

Frequent Co-Authors

Juan J. Gomez-Reino
Juan J. Gomez-Reino University of Santiago de Compostela
Alejandro Balsa
Alejandro Balsa Hospital Universitario La Paz
Laure Gossec
Laure Gossec Sorbonne University
Anthony D. Woolf
Anthony D. Woolf Royal Cornwall Hospital
Maxime Dougados
Maxime Dougados Hôpital Cochin
Daniel Aletaha
Daniel Aletaha Medical University of Vienna
Kimme L. Hyrich
Kimme L. Hyrich University of Manchester
Philip C. Robinson
Philip C. Robinson University of Queensland
Rachelle Buchbinder
Rachelle Buchbinder Monash University
Désirée van der Heijde
Désirée van der Heijde Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine but looking for flexible or alternative options, there are several online degree pathways worth exploring. Many students begin their journey by seeking cheapest rn to bsn online programs, helping registered nurses advance their careers with affordable and accessible education.

For those who want to specialize and move into advanced practice, cheapest online dnp programs offer a practical route to the highest levels in nursing, often at a fraction of the traditional cost. Individuals coming from non-nursing backgrounds can benefit from direct entry msn programs for non-nurses online, fast-tracking their transition into nursing practice.

Online nursing programs are also making entry into healthcare more accessible, especially for those seeking nursing programs with high acceptance rates. Exploring these diverse educational paths can help you find the right fit—whether you're looking to start, advance, or redirect your healthcare career.

Best Scientists Citing Loreto Carmona

Trending Scientists

Recently Published Articles